PPAR-alpha in cutaneous inflammation

Dermato-Endocrinology

Volumn 3, Issue 1, 2011, Pages 23-26

  Dubrac, Sandrine ^a   Schmuth, Matthias ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Allergic contact dermatitis; Atopic dermatitis; PPAR; Psoriasis; Skin barrier

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ATOPIC DERMATITIS; CELL DIFFERENTIATION; CELL PROLIFERATION; ERYTHEMA; GLUCOSE METABOLISM; HUMAN; KERATINOCYTE; LIPID METABOLISM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SKIN ALLERGY; SKIN INFLAMMATION; WOUND HEALING;

EID: 79951799128     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.3.1.14615     Document Type: Review

References (46)

1. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995; 1583:841-50. (Pubitemid 26006526)
2. Desvergne B, Michalik L, Wahli W. Be fit or be sick: peroxisome proliferator-activated receptors are down the road. Mol Endocrinol 2004; 18:1321-32. (Pubitemid 38692172)
3. Chakravarthy MV, Lodhi IJ, Yin L, Malapaka RR, Xu HE, Turk J, et al. Identification of a physiologically relevant endogenous ligand for PPAR-alpha in liver. Cell 2009; 138:476-88.
4. Narala VR, Adapala RK, Suresh MV, Brock TG, Peters-Golden M, Reddy RC. Leukotriene B4 is a physiologically relevant endogenous peroxisome proliferator-activated receptor-alpha agonist. J Biol Chem 2010; 285:22067-74.
5. Glass CK, Ogawa S. Combinatorial roles of nuclear receptors in inflammation and immunity. Nature 2006; 6:44-55. (Pubitemid 43279752)
6. Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W. The PPAR alpha-leukotriene B4 pathway to inflammation control. Nature 1996; 384:39-43. (Pubitemid 26374579)
7. Schmuth M, Watson RE, Deplewski D, Dubrac S, Zouboulis CC, Griffiths CE. Nuclear hormone receptors in human skin. Horm Metab Res 2007; 39:96-105. (Pubitemid 46535567)
8. Schmuth M, Jiang YJ, Dubrac S, Elias PM, Feingold KR. Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology. J Lipid Res 2008; 49:499-509.
9. Braissant O, Wahli W. Differential expression of peroxisome proliferator-activated receptor-alpha, -beta and -gamma during rat embryonic development. Endocrinology 1998; 139:2748-54.
10. Hanley K, Kömüves LG, Bass NM, He SS, Jiang Y, Crumrine D, et al. Fetal epidermal differentiation and barrier development in vivo is accelerated by nuclear hormone receptor activators. J Invest Dermatol 1999; 113:788-95.
11. Michalik L, Desvergne B, Tan NS, Basu-Modak S, Escher P, Rieusset J, et al. Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta mutant mice. J Cell Biol 2001; 154:799-814. (Pubitemid 34292961)
12. Rivier M, Safonova I, Lebrun P, Griffiths CE, Ailhaud G, Michel S. Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes. J Invest Dermatol 1998; 111:1116-21. (Pubitemid 29115184)
13. Westergaard M, Henningsen J, Svendsen ML, Johansen C, Jensen UB, Schrøder HD, et al. Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid. J Invest Dermatol 2001; 116:702-12. (Pubitemid 32467648)
14. Kömüves LG, Hanley K, Man MQ, Elias PM, Williams ML, Feingold KR. Keratinocyte differentiation in hyperproliferative epidermis: topical application of PPARalpha activators restores tissue homeostasis. J Invest Dermatol 2000; 115:361-7.
15. Man MQ, Choi EH, Schmuth M, Crumrine D, Uchida Y, Elias PM, et al. Basis for improved permeability barrier homeostasis induced by PPAR and LXR activators: liposensors stimulate lipid synthesis, lamellar body secretion and post-secretory lipid processing. J Invest Dermatol 2006; 126:386-92.
16. Kim MJ, Deplewski D, Ciletti N, Michel S, Reichert U, Rosenfield RL. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development. Mol Genet Metab 2001; 74:362-9. (Pubitemid 33111918)
17. Downie MM, Sanders DA, Maier LM, Stock DM, Kealey T. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro. Br J Dermatol 2004; 151:766-75. (Pubitemid 39482109)
18. Alestas T, Ganceviciene R, Fimmel S, Müller-Decker K, Zouboulis CC. Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med 2006; 84:75-87. (Pubitemid 43099526)
19. Dubrac S, Stoitzner P, Pirkebner D, Elentner A, Schoonjans K, Auwerx J, et al. Peroxisome proliferator-activated receptor-alpha activation inhibits Langerhans cell function. J Immunol 2007; 178:4362-72. (Pubitemid 46492387)
20. Babaev VR, Ishiguro H, Ding L, Yancey PG, Dove DE, Kovacs WJ, et al. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2007; 116:1404-12. (Pubitemid 47417567)
21. Dunn SE, Ousman SS, Sobel RA, Zuniga L, Baranzini SE, Youssef S, et al. Peroxisome proliferator-activated receptor (PPAR)-alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity. J Exp Med 2007; 204:321-30. (Pubitemid 46294548)
22. Jones DC, Ding X, Zhang TY, Daynes RA. Peroxisome proliferator-activated receptor-alpha negatively regulates T-bet transcription through suppression of p38 Mitogen-Activated Protein Kinase activation. J Immunol 2003; 171:196-203. (Pubitemid 36745288)
23. Cunard R, DiCampli D, Archer DC, Stevenson JL, Ricote M, Glass CK, et al. Wy-14643, a PPAR alpha ligand, has profound effects on immune responses in vivo. J Immunol 2002; 169:6806-12. (Pubitemid 36899265)
24. Petrosino S, Cristino L, Karsak M, Gaffal E, Ueda N, Tüting T, et al. Protective role of palmitoylethanolamide in contact allergic dermatitis. Allergy 2010; 65:698-711.
25. Staumont-Sallé D, Abboud G, Brénuchon C, Kanda A, Roumier T, Lavogiez C, et al. Peroxisome proliferator-activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis. J Allergy Clin Immunol 2008; 121:962-8.
26. Plager DA, Leontovich AA, Henke SA, Davis MD, McEvoy MT, Sciallis GF, 2nd, et al. Early cutaneous gene transcription changes in adult atopic dermatitis and potential clinical implications. Exp Dermatol 2007; 16:28-36. (Pubitemid 44890348)
27. Westergaard M, Henningsen J, Johansen C, Rasmussen S, Svendsen ML, Jensen UB, et al. Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin. J Invest Dermatol 2003; 121:1104-17. (Pubitemid 37430980)
28. Mössner R, Kaiser R, Matern P, Krüger U, Westphal GA, Brockmöller J, et al. Variations in the genes encoding the peroxisome proliferator-activated receptors alpha and gamma in psoriasis. Arch Dermatol Res 2004; 296:1-5. (Pubitemid 38828416)
29. Törmä H, Berne B. Sodium lauryl sulphate alters the mRNA expression of lipid-metabolizing enzymes and PPAR signalling in normal human skin in vivo. Exp Dermatol 2009; 18:1010-5.
30. Sheu MY, Fowler AJ, Kao J, Schmuth M, Schoonjans K, Auwerx J, et al. Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models. J Invest Dermatol 2002; 118:94-101. (Pubitemid 34107429)
31. Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, et al. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol 2005; 67:15-9. (Pubitemid 40069962)
32. Schmid HH, Schmid PC, Natarajan V. The N-acylation-phosphodiesterase pathway and cell signalling. Chem Phys Lipids 1996; 80:133-42. (Pubitemid 26197041)
33. Cadas H, di Tomaso E, Piomelli D. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J Neurosci 1997; 17:1226-42. (Pubitemid 27073726)
34. Hansen HS, Lauritzen L, Moesgaard B, Strand AM, Hansen HH. Formation of N-acyl-phosphatidylethanolamines and N-acetylethanolamines: proposed role in neurotoxicity. Biochem Pharmacol 1998; 55:719-25. (Pubitemid 28319635)
35. Dubusquoy L, Piccardi N, Msika P, Auwerx J, Chambon P. Sunflower oleodistillate - a new natural PPAR alpha activator with anti-inflammatory properties. J Invest Dermatol 2005; 124:59.
36. Hatano Y, Man MQ, Uchida Y, Crumrine D, Mauro TM, Feingold KR, et al. Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators. J Allergy Clin Immunol 2010; 125:160-9.
37. Kippenberger S, Loitsch SM, Grundmann-Kollmann M, Simon S, Dang TA, Hardt-Weinelt K, et al. Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation. J Invest Dermatol 2001; 117:1430-6. (Pubitemid 34032769)
38. Eichenfield LF, McCollum A, Msika P. The benefits of sunflower oleodistillate (SOD) in pediatric dermatology. Pediatr Dermatol 2009; 26:669-75.
39. Piccardi N, Piccirilli A, Choulot JC, Msika P. Sunflower oil oleodistillate for atopy treatment: an in vitro and clinical evaluation. J Invest Dermatol 2001; 117:390-423.
40. Eberlein B, Eicke C, Reinhardt HW, Ring J. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). J Eur Acad Dermatol Venereol 2008; 22:73-82.
41. Daynes R, Jones DC. Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2002; 2:748-59. (Pubitemid 37328715)
42. Elentner A, Finke D, Schmuth M, Chappaz S, Ebner S, Malissen B, et al. Langerhans cells are critical in the development of atopic dermatitis-like inflammation and symptoms in mice. J Cell Mol Med 2009; 13:2658-72.
43. Dubrac S, Schmuth M, Ebner S. Atopic dermatitis: the role of Langerhans cells in disease pathogenesis. Immunol Cell Biol 2010; 88:400-9.
44. Cuzzocrea S, Mazzon E, Di Paola R, Peli A, Bonato A, Britti D, et al. The role of the peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in the regulation of acute inflammation. J Leukocyte Biol 2006; 79:999-1010. (Pubitemid 44835587)
45. Dubrac S, Elentner A, Schoonjans K, Auwerx J, Schmuth M. PPAR-alpha deficiency triggers allergic contact dermatitis by affecting regulatory T cells through lack of IL-2. J Invest Dermatol 2010; 130.
46. Cuzzocrea S, Bruscoli S, Mazzon E, Crisafulli C, Donato V, Di Paola R, et al. Peroxisome proliferator-activated receptor-alpha contributes to the anti-inflammatory activity of glucocorticoids. Mol Pharmacol 2008; 73:323-37. (Pubitemid 351181185)